Evidence map›Paper›PMID 41385325›Full record

ArticleNucleic acids research2025

The RNA-binding protein PRRC2B preserves 5' TOP mRNA during starvation to maintain ribosome biogenesis during nutrient recovery.

Nadav Goldberg, Doron Bril, Miriam Eisenstein, Tsviya Olender, Alon Savidor, Shani Bialik, Shmuel Pietrokovski, Adi Kimchi

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nadav GoldbergDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Doron BrilDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Miriam EisensteinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Tsviya OlenderDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Alon SavidorThe de Botton Institute for Protein Profiling of the Nancy and Stephen Grand Israel National Center for Personalized Medicine (G-INCPM), Weizmann Institute of Science, Rehovot 7610001, Israel.
Shani BialikDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Shmuel PietrokovskiDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Adi KimchiDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0002-8236-8989

Funding

Abisch-Frenkel RNA Therapeutics Center of the Weizmann Institute of Science to AKWeizmann Institute of Science
6 · The paper itself

Abstract

PRRC2B is an intrinsically disordered RNA-binding protein that is part of the cell's translation machinery. Here, we show that PRRC2B has two alternatively spliced mRNA transcripts producing major long and minor short isoforms. Mass spectrometry-based interaction studies indicated that both isoforms associate with the 40S ribosomal subunit and translation initiation factors. Importantly, the long isoform also interacted with additional RNA-binding proteins through its unique Arg/Gly-rich region. Among these is LARP1, a regulator of 5' terminal oligopyrimidine (TOP) mRNAs under conditions of mTOR inhibition. We discovered that, like LARP1, PRRC2B-long isoform binds to 5' TOP mRNAs. Moreover, it is necessary for the post-transcriptional preservation of their mRNA levels, particularly those encoding ribosomal proteins, during amino acid starvation. In its absence, the rapid de novo translation of ribosomal proteins that takes place upon nutrient recovery is impeded. Overall, our study elucidates a newly discovered function for PRRC2B as an RNA-binding protein that regulates ribosomal biogenesis upon metabolic shift, in addition to its established function in initiating translation of specific mRNA targets.

Indexed as

RibosomesRNA 5' Terminal Oligopyrimidine SequenceRNA-Binding ProteinsRNA, MessengerAlternative SplicingAutoantigensHEK293 CellsHumansNutrientsProtein BiosynthesisProtein IsoformsRibonucleoproteinsRibosomal ProteinsRibosome Subunits, Small, EukaryoticSS-B AntigenAutoantigensNutrientsProtein IsoformsRibonucleoproteinsRibosomal ProteinsRNA-Binding ProteinsRNA, MessengerSS-B Antigen

Identifiers

PMID41385325
PMCPMC12700102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.